4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-20-001675
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rubin Steven D · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-19 | Grant or award : show line 1 in the form Stock Options (right to buy) | +20,000 | 20,000 | D |
Loading xslF345X03/form4-06232020_050639.xml…